AlzeCure Pharma: AlzeCure Gets Abstract on New Clinical Stud

STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden , San Diego , California , United States , Stockholm , Swedish , Alzecure Pharma , Johan Sandin , Neurotrophin Trk , Matthias Rother , Boel Nilsson , Results From , Multiple Ascending Dose Study , Healthy Volunteers , Positive Modulator , Neurotrophin Trk Receptors , Clinical Trial Manager , Medical Program Director , Nasdaq First North Premier Growth Market , Nerve Growth Factor , Brain Derived Neurotrophic Factor , Alzecure , Dharma , Jets , Abstract , Linical , Study , Data , Neurorestore , Accepted , Lzheimer , Conference , Aic ,